FindTrial
Sign In

Medical records based retrospective study on the evaluation of the efficacy of drug treatment after conservative surgery for adenomyosis

Comparing recurrence rate and related factors between combination therapy and conservative operation only in adenomyosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033696
Enrollment
Unknown
Registered
2020-06-09
Start date
2020-06-08
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

combined with GnRHa group after operation vs.non-treatment group:N/A

Sponsors

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with adenomyosis diagnosed pathologically; 2. Subjects aged 18-50 years; 3. Patients who received initial treatment (no steroids before treatment); 4. The object of previous physical fitness, non pregnancy.

Exclusion criteria

Exclusion criteria: 1. Patients with ovarian endometriosis or deep invasive endometriosis or multiple leiomyomas; 3. Patients treated with steroids before treatment; 4. Patients with genetic diseases, blood diseases, liver and kidney dysfunction or malnutrition that cause anemia.

Design outcomes

Primary

MeasureTime frame
size of lesion;VRS;PBLAC;—

Countries

China

Contacts

Public ContactWang Shixuan

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

sxwang@tjh.tjmu.edu.cn+86 13995553319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026